Anders Elm Pedersen

Anders Elm Pedersen

Guest researcher


Publication year:
All
1 - 4 out of 4Page size: 10
  1. 2008
  2. Published

    Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.

    Svane, I. M., Pedersen, Anders Elm, Nikolajsen, K. & Zocca, M., 2008, In: Vaccine. 26, 36, p. 4716-24 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.

    Trepiakas, R., Pedersen, Anders Elm, Met, Özcan, Hansen, M. H., Berntsen, A. & Svane, I. M., 2008, In: Vaccine. 26, 23, p. 2824-32 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model

    Pedersen, Anders Elm, Schmidt, E. G. W., Gad, M., Poulsen, Steen Seier & Claesson, Mogens Helweg, 2008, In: Immunology.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.

    Berntsen, A., Trepiakas, R., Wenandy, L., Geertsen, P. F., thor Straten, P., Andersen, M. H., Pedersen, Anders Elm, Claesson, Mogens Helweg, Lorentzen, T., Johansen, J. S. & Svane, I. M., 2008, In: Journal of Immunotherapy. 31, 8, p. 771-80 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 8473